BOSTON and MIAMI, Oct. 8, 2020 /PRNewswire/ -- Aegle Therapeutics Corporation, a first-in-class biotechnology company developing extracellular vesicles as therapy, today announced that the Company has been awarded a grant by the U.S. DoD\'s CDMRP to fund the continued development of the...
For more information, please visit
https://www.prnewswire.com:443/news-rele[...]ent-of-agle-102-301148020.html